These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20164783)

  • 1. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention.
    Maioli M; Toso A; Gallopin M; Leoncini M; Tedeschi D; Micheletti C; Bellandi F
    J Cardiovasc Med (Hagerstown); 2010 Jun; 11(6):444-9. PubMed ID: 20164783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Chen YL; Fu NK; Xu J; Yang SC; Li S; Liu YY; Cong HL
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E8-16. PubMed ID: 23907993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.
    Mehran R; Aymong ED; Nikolsky E; Lasic Z; Iakovou I; Fahy M; Mintz GS; Lansky AJ; Moses JW; Stone GW; Leon MB; Dangas G
    J Am Coll Cardiol; 2004 Oct; 44(7):1393-9. PubMed ID: 15464318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure.
    Cho JY; Jeong MH; Hwan Park S; Kim IS; Park KH; Sim DS; Yoon NS; Yoon HJ; Park HW; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2010 Nov; 56(3):300-6. PubMed ID: 20708903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography.
    Liu Y; He YT; Tan N; Chen JY; Liu YH; Yang DH; Huang SJ; Ye P; Li HL; Ran P; Duan CY; Chen SQ; Zhou YL; Chen PY
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25888371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes.
    Zhang MM; Lv QZ; Li XY
    Am J Ther; 2017; 24(4):e423-e430. PubMed ID: 26308327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHADS2 score predicts risk of contrast-induced nephropathy in stable coronary artery disease patients undergoing percutaneous coronary interventions.
    Chou RH; Huang PH; Hsu CY; Leu HB; Huang SS; Huang CC; Chen JW; Lin SJ
    J Formos Med Assoc; 2016 Jul; 115(7):501-9. PubMed ID: 26830105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-induced nephropathy in urgent coronary interventions.
    Valente S; Lazzeri C; Giglioli C; Margheri M; Comeglio M; Nicolaci L; Chechi T; Gensini GF
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):737-41. PubMed ID: 17001234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
    Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
    Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
    Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
    Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk score for contrast induced nephropathy following percutaneous coronary intervention.
    Ghani AA; Tohamy KY
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):240-5. PubMed ID: 19237811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.
    Ivanes F; Isorni MA; Halimi JM; Fauchier L; Saint Etienne C; Babuty D; Angoulvant D; Brunet-Bernard A
    Arch Cardiovasc Dis; 2014; 107(8-9):424-32. PubMed ID: 25082735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
    Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
    Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.